CLNN

3.5200.57%
DJ

David J. Matlin

Independent Chairman of the Board

Mr. David Jeffrey Matlinn, J.D., is Director of DermaSensor, Inc. from 2018. Mr. Matli is Chairman at Clene Nanomedicine, Inc. He is Independent Director of TriSalus Life Sciences, Inc. since August 10, 2023. He serves as Director of Pristine Surgical LLC. He is an Independent Director at Clene Inc. since December 2020 and also serves as its Chairman of the Board since May 2021. He has been the Chief Financial Officer and Director of MedTech Acquisition Corporation since September 11, 2020. Mr. Matlin serves as Director at U.S. Well Services, Inc. (formerly, Matlin & Partners Acquisition Corporation) since 2016 and previously served as its Chairman since November 9, 2018. Mr. Matlin was, until April 2021, the Chief Executive Officer of MatlinPatterson Global Advisers LLC. He Co-Founded Matlin Patterson Global Advisers LLC in July 2002. Previously, he was a Chief Investment Officer at the firm. Mr. Matlin has overall responsibility of MatlinPatterson's distressed credit strategies. Mr. Matlin was also Chief Executive Officer of MatlinPatterson Asset Management L.P. and its operating joint venture affiliates that managed non-distressed credit strategies, from 2015 to 2018. Prior to forming MatlinPatterson in 2002, he was a Managing Director at Credit Suisse First Boston and Head of the Credit Suisse Distressed Securities Group since its inception in 1994. He co-founded Merrion Group, LP and served as the Managing Director and Founding Partner from 1988 to 1994. Mr. Matlin served as a Manager at Huntsman Advanced Materials LLC. From 1986 to 1988, he served as a Securities Analyst at Halcyon Investments. He was Director of OrthoSensor, Inc. until the sale to Stryker Corp. in December 2020. He was Director of Huntsman Corporation between 2005 and 2007. He was a Director of Flagstar Bank, FSB. He was a Director of CalAtlantic Group, Inc. (formerly, Standard Pacific Corp.) since July 29, 2008 until 2018. Mr. Matlin also serves on the Board of Directors of US Well Services Incorporated and was its Chief Executive Officer. Since September 2020, he has served on the Board of Oceanus LLC. Since December 2020, he has been an observer of the Board of Clene Nanomedicine, Incorporateda biopharmaceutical manufacturer and since 2020, he has served on the Board of Traffk, LLC, an insurance-based data analytics company. Mr. Matlin served as a Director or Manager of HMP Equity Holdings Corporation (HMP) and certain of Huntsman Corp's subsidiaries. He served as a Director of Global Aviation Holdings, Inc. from November 2006 to February 1, 2012 and served as Director at Flagstar BanCorp, Inc. since January 30, 2009 until May 25, 2021. Mr. Matlin served as a Director of Huntsman Corp. from October 2004 to August 2007 and Thornburg Mortgage Inc. from April 22, 2008 to March 12, 2009. He served as a Director of Huntsman International LLC. Mr. Matlin served as a Manager/Director of Huntsman International Holdings LLC (HIH) and its subsidiaries, Huntsman LLC (HLLC) and AdMat. He served as a Director of Icon Health & Fitness Inc. since September 1999. Mr. Matlin was Special Advisor of Long Table Growth Corp. from June 3, 2026 and serves as its Strategic Advisor. Mr. Matlin was a Director of MCI Group since August 29, 2003, WorldCom Inc. since August 2003 and Victor Forstmann, Inc. since October 1998. He has been an active participant in the distressed securities market for many years and has made investments in more than 25 countries in North America, Latin America, Asia, Europe and Australia. He privately held Dermasensor, Inc., Pristine Surgical, LLC, Traffk, LLC and Empyrean Neuroscience, Incorporated. Mr. Matlin received a Juris Doctor from the Law School of the University of California at Los Angeles in 1986 and a BS in Economics from the Wharton School of the University of Pennsylvania in 1983.

Positions